Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT06421415
Recruiting Observational

Long Term Effect of AIT in Children

NCT06421415 · tracked via the Priya Life Science Denmark tracker
Sponsor
Odense University Hospital
Phase
Observational
Started
2024-05-01
Last updated
2025-07-10

Condition(s) studied

Allergy in Children

Investigational drug(s) / intervention(s)

Allergen Immunotherapy Extract

Allergen Immunotherapy Extract: Patients will be treated as usual. The study is an observation of the long term effect of the treatment

Study summary

The present study will investigate the long term effect of allergen immunotherapy in a real-life study in children with allergy undergoing subcutaneous or sublingual immunotherapy with grass pollen, birch, house dust mites or venom.

Eligibility

Sex
ALL
Min age
4 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: treated with allergen immunotherapy at HCA Children'sHospital, Odense University Hospital - Exclusion Criteria: received less than 12 months of treatment with allergen immunotherapy \-

Primary outcome measure(s)

  • Effect of immunotherapy 5 years after end of treatment — 5 years
    Medication use for allergy and asthma and the patient's experience of effect of the AIT on a scale from 0-4 (0= no effect, 1= modest effect, 2= some effect, 3= good effect, 4= very good effect)

Trial sites (2)

FacilityCityRegionStatus
Hans Christian Andersen Children's Hospital Odense Odense C Recruiting
Hans Christian Andersen Children's Hospital Odense Denmark Recruiting

More Odense University Hospital trials in Denmark

Ultrasound Applicability in the Assessment of Patients With Fibrosing Interstitial Lung Disease Enrolling by invitation
Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring Recruiting
Immunotherapy in Patients With Early dMMR Rectal Cancer Recruiting
Permissive Hyperthermia in Acute Brain Injury Active, not recruiting
Vitamin D and Angiogenic Markers in Odense Child Cohort 1 Active, not recruiting

Other trials for the same condition

Allergen Provocations- HCA Children's Hospital Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06421415 on ClinicalTrials.gov ↗ ← All trials in Denmark